{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:22:38Z","timestamp":1781940158055,"version":"3.54.5"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Familial non-medullary thyroid cancer (FNMTC) is a form of endocrine malignancy exhibiting an autosomal dominant mode of inheritance with largely unknown germline molecular mechanism. Hereditary nonpolyposis colorectal cancer syndrome (HNPCC) is another hereditary autosomal dominant cancer syndrome which, if proven to be caused by germline mutations in mismatch repair genes (MMR)\u2014<jats:italic>MLHL<\/jats:italic>,\u00a0<jats:italic>MSH2<\/jats:italic>,\u00a0<jats:italic>MSH6<\/jats:italic>,\u00a0<jats:italic>PMS2<\/jats:italic>, and\u00a0<jats:italic>EPCAM<\/jats:italic>\u2014is called Lynch syndrome (LS). LS results in hereditary predisposition to a number of cancers, especially colorectal and endometrial cancers. Tumors in LS are characterized by microsatellite instability (MSI) and\/or loss of MMR protein expression in immunohistochemistry (IHC). MSI is a rare event in thyroid cancer (TC), although it is known to occur in up to 2.5% of sporadic follicular TC cases. There are limited data on the role of germline MMR variants FNMTC. The goal of this study was to analyze the potential clinical and molecular association between HNPCC and FNMTC. We performed a cohort study analyzing the demographic, clinical, and pathologic data of 43 kindreds encompassing 383 participants (104 affected, 279 unaffected), aged 43.5 [7-99] years with FNMTC, and performed high-throughput whole-exome sequencing (WES) of peripheral blood DNA samples of selected 168 participants (54 affected by FNMTC and 114 unaffected). Total affected by thyroid cancer members per family ranged between 2 and 9 patients. FNMTC was more prevalent in women (68.3%) and characterized by a median tumor size of 1.0 [0.2-5.0] cm, multifocal growth in 44%, and gross extrathyroidal extension in 11.3%. Central neck lymph node metastases were found in 40.3% of patients at presentation, 12.9% presented with lateral neck lymph node metastases, and none had distant metastases. Family history screening revealed one Caucasian family meeting the clinical criteria for FNMTC and HNPCC, with five members affected by FNMTC and at least eight individuals reportedly unaffected by HNPCC-associated tumors. In addition, two family members were affected by melanoma. Genome Analysis Tool Kit (GATK) pipeline was used in variant analysis. Among 168 sequenced participants, a heterozygous missense variant in the <jats:italic>MSH2<\/jats:italic> gene (rs373226409; c.2120G&amp;gt;A; p.Cys707Tyr) was detected exclusively in FNMTC- HNPCC- kindred. In this family, the sequencing was performed in one member affected by FNMTC, HPNCC-associated tumors and melanoma, one member affected solely by HNPCC-associated tumor, and one member with FNMTC only, as well as seven unaffected family members. The variant was present in all three affected adults, and in two unaffected children of the affected member, under the age of 18 years, and was absent in non-affected adults. This variant is\u00a0predicted to be damaging\/pathogenic in 17\/20 <jats:italic>in-silico<\/jats:italic> models. However, immunostaining performed on the thyroid tumor tissue of two affected by FNMTC family members revealed intact nuclear expression of <jats:italic>MSH2<\/jats:italic>, and microsatellite stable status in both tumors that were tested. Although the <jats:italic>MSH2<\/jats:italic> p.Cys707Tyr variant is rare with a minor allele frequency (MAF) of 0.00006 in Caucasians; it is more common in the South Asian population at 0.003 MAF. Therefore, the <jats:italic>MSH2<\/jats:italic> variant observed in this family is unlikely to be an etiologic factor of thyroid cancer and a common genetic association between FNMTC and HNPCC has not yet been identified. This is the first report known to us on the co-occurrence of FNMTC and HNPCC. The co-occurrence of FNMTC and HNPCC-associated tumors is a rare event and although presented in a single family in our large FNMTC cohort, a common genetic background between the two comorbidities could not be established.<\/jats:p>","DOI":"10.3389\/fendo.2021.653401","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T15:17:02Z","timestamp":1626189422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors\u2014A Cohort Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Kshama","family":"Aswath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Gubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmasree","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirisha","family":"Avadhanula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer Kumar","family":"Gara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Dikoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Klubo-Gwiezdzinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-91725-2_20","article-title":"Familial Non-Medullary Thyroid Cancer","author":"Klubo-Gwiezdzinska","year":"2017","journal-title":"Practical Management of Thyroid Cancer - A Multidisciplinary Approach, second edition"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0406","article-title":"Clinical Characteristics and Outcome of Familial Nonmedullary Thyroid Cancer: A Retrospective Controlled Study","volume":"21","author":"Robenshtok","year":"2011","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0960","article-title":"Endocrine Tumours: Familial Nonmedullary Thyroid Carcinoma Is a More Aggressive Disease: A Systematic Review and Meta-Analysis","volume":"172","author":"Wang","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"948786","DOI":"10.1155\/2011\/948786","article-title":"Familial Papillary Thyroid Carcinoma: A Retrospective Analysis","volume":"2011","author":"McDonald","year":"2011","journal-title":"J Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.181","article-title":"On the Prevalence of Familial Nonmedullary Thyroid Cancer in Multiply Affected Kindreds","volume":"16","author":"Charkes","year":"2006","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0668","article-title":"Results of Screening in Familial Non-Medullary Thyroid Cancer","volume":"27","author":"Klubo-Gwiezdzinska","year":"2017","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.23736\/S2724-6507.20.03338-6","article-title":"Familial Non-Medullary Thyroid Carcinoma: Clinico-Pathological Features, Current Knowledge and Novelty Regarding Genetic Risk Factors","volume":"46","author":"Cirello","year":"2020","journal-title":"Minerva Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502449","article-title":"Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer","volume":"373","author":"Gara","year":"2015","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0736","article-title":"Identification of Rare Variants Predisposing to Thyroid Cancer","volume":"29","author":"Wang","year":"2019","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04505.x","article-title":"FOXE1 Polymorphisms Are Associated With Familial and Sporadic Nonmedullary Thyroid Cancer Susceptibility","volume":"77","author":"Tomaz","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.20944\/preprints201910.0154.v1","article-title":"Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK\/ERK and PI3K\/AKT Signaling Pathways","volume":"9","author":"Srivastava","year":"2019","journal-title":"Biomolecules"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0214","article-title":"Familial Non-Medullary Thyroid Carcinoma (FNMTC): Analysis of fPTC\/PRN, NMTC1, MNG1 and TCO Susceptibility Loci and Identification of Somatic BRAF and RAS Mutations","volume":"15","author":"Cavaco","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0270","article-title":"Telomere Length Is Shorter in Affected Members of Families With Familial Nonmedullary Thyroid Cancer","volume":"23","author":"He","year":"2013","journal-title":"Thyroid"},{"key":"B15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.23736\/S0391-1977.20.03252-6","article-title":"Codon Bias Analyses on Thyroid Carcinoma Genes","volume":"45","author":"Pepe","year":"2020","journal-title":"Minerva Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Institute"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.000000000000000","article-title":"Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer","volume":"57","author":"Giardiello","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"170432","DOI":"10.1155\/2010\/170432","article-title":"Current Hypotheses on How Microsatellite Instability Leads to Enhanced Survival of Lynch Syndrome Patients","volume":"2010","author":"Drescher","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0655","article-title":"Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers","volume":"29","author":"Genutis","year":"2019","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and Accurate Short Read Alignment With Burrows-Wheeler Transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce Framework for Analyzing Next-Generation DNA Sequencing Data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"201178","DOI":"10.1101\/201178","article-title":"Scaling Accurate Genetic Variant Discovery to Tens of Thousands of Samples","author":"Poplin","year":"2018","journal-title":"bioRxiv"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11 10 1","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ Data to High Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinf"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz966","article-title":"Ensembl 2020","volume":"48","author":"Yates","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"8 16 1","DOI":"10.1002\/0471142905.hg0816s89","article-title":"Using ClinVar as a Resource to Support Variant Interpretation","volume":"89","author":"Harrison","year":"2016","journal-title":"Curr Protoc Hum Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2019.04.009","article-title":"Can Predicted Protein 3d Structures Provide Reliable Insights Into Whether Missense Variants Are Disease Associated","volume":"431","author":"Ittisoponpisan","year":"2019","journal-title":"J Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/ey.17.14.3","article-title":"The Mutational Constraint Spectrum Quantified From Variation in 141,456 Humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: The Human Genomic Variant Search Engine","volume":"35","author":"Kopanos","year":"2018","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: A Comprehensive Refinement of the ACMG\u2013AMP Variant Classification Criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08004-0","article-title":"Familial Papillary Thyroid Microcarcinoma: A New Clinical Entity","volume":"353","author":"Lupoli","year":"1999","journal-title":"Lancet (London England)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.6120","article-title":"Development and Validation of the PREMM(5) Model for Comprehensive Risk Assessment of Lynch Syndrome","volume":"35","author":"Kastrinos","year":"2017","journal-title":"J Clin Oncol"},{"key":"B33","article-title":"Mutational Landscape of Metastatic Cancer Revealed From Prospective Clinical Sequencing of 10,000 Patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13053-019-0128-2","article-title":"Prevalence and Spectrum of MLH1, MSH2, and MSH6 Pathogenic Germline Variants in Pakistani Colorectal Cancer Patients","volume":"17","author":"Rashid","year":"2019","journal-title":"Hereditary Cancer Clin Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1897-4287-6-1-15","article-title":"Thyroid Cancer in a Patient With a Germline MSH2 Mutation. Case Report and Review of the Lynch Syndrome Expanding Tumour Spectrum","volume":"6","author":"Stulp","year":"2008","journal-title":"Hereditary Cancer Clin Pract"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000333","article-title":"Defining the Adenoma Burden in Lynch Syndrome","volume":"58","author":"Kalady","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000332","article-title":"Colonic Polyps in Lynch Syndrome","volume":"58","author":"Burt","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-013-9611-5","article-title":"How Do We Approach the Goal of Identifying Everybody With Lynch Syndrome","volume":"12","author":"Hampel","year":"2013","journal-title":"Familial Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-004-5811-3","article-title":"The Incidence of Lynch Syndrome","volume":"4","author":"de la Chapelle","year":"2005","journal-title":"Familial Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043146","article-title":"Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)","volume":"352","author":"Hampel","year":"2005","journal-title":"New Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.5950","article-title":"Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer","volume":"26","author":"Hampel","year":"2008","journal-title":"J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382101","article-title":"Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease","volume":"338","author":"Aaltonen","year":"1998","journal-title":"New Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.11.2193","article-title":"Population-Based Molecular Detection of Hereditary Nonpolyposis Colorectal Cancer","volume":"18","author":"Salovaara","year":"2000","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13468","article-title":"Tumor Testing to Identify Lynch Syndrome in Two Australian Colorectal Cancer Cohorts","volume":"32","author":"Buchanan","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300041","article-title":"Comparison Between Universal Molecular Screening for Lynch Syndrome and Revised Bethesda Guidelines in a Large Population-Based Cohort of Patients With Colorectal Cancer","volume":"61","author":"P\u00e9rez-Carbonell","year":"2012","journal-title":"Gut"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyw178","article-title":"Prevalence of Lynch Syndrome and Lynch-Like Syndrome Among Patients With Colorectal Cancer in a Japanese Hospital-Based Population","volume":"47","author":"Chika","year":"2017","journal-title":"Japanese J Clin Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e79737","DOI":"10.1371\/journal.pone.0079737","article-title":"Prevalence of Lynch Syndrome Among Patients With Newly Diagnosed Endometrial Cancers","volume":"8","author":"Egoavil","year":"2013","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary Colorectal Cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.01.035","article-title":"Aberrant DNA Methylation in Hereditary Nonpolyposis Colorectal Cancer Without Mismatch Repair Deficiency","volume":"138","author":"Goel","year":"2010","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13053-018-0098-9","article-title":"A Retrospective Study of Extracolonic, Non-Endometrial Cancer in Swedish Lynch Syndrome Families","volume":"16","author":"Karimi","year":"2018","journal-title":"Hereditary Cancer Clin Pract"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-012-9534-6","article-title":"Cancer Spectrum in DNA Mismatch Repair Gene Mutation Carriers: Results From a Hospital Based Lynch Syndrome Registry","volume":"11","author":"Pande","year":"2012","journal-title":"Fam Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800150","article-title":"Unusual Tumors Associated With the Hereditary Nonpolyposis Colorectal Cancer Syndrome","volume":"17","author":"Broaddus","year":"2004","journal-title":"Modern Pathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopha.2015.06.008","article-title":"Papillary Thyroid Carcinoma (PTC) in Lynch Syndrome: Report of Two Cases and Discussion on Lynch Syndrome Behaviour and Genetics","volume":"74","author":"Pelizzo","year":"2015","journal-title":"BioMed Pharmacother"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S121812","article-title":"Thyroid Cancer in a Patient With Lynch Syndrome - Case Report and Literature Review","volume":"13","author":"Fazekas-Lavu","year":"2017","journal-title":"Ther Clin Risk Manage"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8103","article-title":"Mismatch Repair Single Nucleotide Polymorphisms and Thyroid Cancer Susceptibility","volume":"15","author":"Santos","year":"2018","journal-title":"Oncol Lett"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0716","article-title":"Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas","volume":"29","author":"Wong","year":"2019","journal-title":"Thyroid"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/path.5359","article-title":"Whole-Genome Sequencing of Synchronous Thyroid Carcinomas Identifies Aberrant DNA Repair in Thyroid Cancer Dedifferentiation","volume":"250","author":"Paulsson","year":"2020","journal-title":"J\u00a0Pathol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-017-4299-6","article-title":"DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid Cancers","volume":"42","author":"Javid","year":"2018","journal-title":"World J Surg"},{"key":"B59","article-title":"Analysis of DNA Mismatch Repair Gene Expression and Mutations in Thyroid Tumours","volume":"26","author":"Ruschenburg","year":"2006","journal-title":"Anticancer Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733","article-title":"Mismatch Repair Deficiency Predicts Response of Solid Tumors to PD-1 Blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(01)00656-2","article-title":"Evaluation of Adult Papillary Thyroid Carcinomas by Comparative Genomic Hybridization and Microsatellite Instability Analysis","volume":"135","author":"Bauer","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"B62","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64546-4","article-title":"Germline and Somatic Mutation Analysis of MLH3 in MSI-Positive Colorectal Cancer","volume":"157","author":"Loukola","year":"2000","journal-title":"Am\u00a0J\u00a0Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.417","article-title":"Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients \u226450: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery","volume":"110","author":"Karlitz","year":"2015","journal-title":"Off J Am Coll Gastroenterol | ACG"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.113620","article-title":"Germline Characterization of Early-Aged Onset of Hereditary Non-Polyposis Colorectal Cancer","volume":"138","author":"Huang","year":"2001","journal-title":"J Pediatr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000179","article-title":"Lynch Syndrome: A Pediatric Perspective","volume":"58","author":"Huang","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3106","article-title":"A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome","volume":"97","author":"Guerra","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.653401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T15:17:12Z","timestamp":1626189432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.653401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":67,"alternative-id":["10.3389\/fendo.2021.653401"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.653401","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"article-number":"653401"}}